Dr. Ryan Sullivan, MD
Dr. Ryan Sullivan, MD is a medical oncologist in Boston, MA and has over 20 years of experience in the medical field. He graduated from University of Connecticut Health Center in 2001. He is affiliated with medical facilities such as Brigham and Women's Hospital and Massachusetts General Hospital. He is not accepting new patients.
Practice
55 Fruit St Boston, MA 02114Make an Appointment
Compare with other Medical Oncologists
Compare Dr. Sullivan with our nearby Medical Oncologists at Tufts Medical Center.
Make an appointment at Tufts Medical Center today at
(617) 263-8322.
Experience Check
Search for experience in a specific area
Dr. Sullivan's Reviews
Likelihood to recommend Dr. Sullivan
5.0
| 5 Star | 100% | 100% |
| 4 Star | 0% | 0% |
| 3 Star | 0% | 0% |
| 2 Star | 0% | 0% |
| 1 Star | 0% | 0% |
Overall Patient Satisfaction
Likelihood of recommending Dr. Sullivan to family and friends is 5 out of 5
About Me
biography
Dr. Ryan Sullivan, MD is a medical oncologist in Boston, MA and has over 20 years of experience in the medical field. He graduated from University of Connecticut Health Center in 2001. He is affiliated with medical facilities such as Brigham and...read moreMedical Oncology
*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
University Of Connecticut Health Center
Medical School, 2001
Healthgrades receives board action history for physicians and physician assistants. The information displayed here is sourced from independent information providers, such as state board websites, and may not be the most up-to-date information. Healthgrades makes no representations with respect to the accuracy of any information provided here and assumes no responsibility or liability for such information.
Learn more about medical license public record checkThe State of Melanoma: Emergent Challenges and Opportunities, 2021-01-07
Immune Checkpoint Inhibitors for Cancer and Venous Thromboembolic Events, 2021-10-15
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq, 2016-04-08
The "Great Debate” at Immunotherapy Bridge 2020, December 3rd, 2020, 2021-04-07
Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy, 2020-06-29
Clinical utility of a blood-based BRAF V600E mutation assay in melanoma, 2014-10-15
Isolation and Molecular Characterization of Circulating Melanoma Cells, 2014-04-18
Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis, 2021-10-12
Mechanisms of Resistance to Immune Checkpoint Blockade, 2018-10-05
Developments in the space of new MAPK pathway inhibitors for BRAF-mutant melanoma, 2019-04-16
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade, 2018-11-01
STAG2 regulates interferon signaling in melanoma via enhancer loop reprogramming, 2022-04-06
Toxicities associated with immune checkpoint inhibitors: a systematic study, 2023-05-03
Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer, 2021-12-09
Phase Ib/II, open-label, dose-escalation study of LGX818, an oral selective BRAF inhibitor, in combination with MEK162, an oral MEK1/2 inhibitor, in patients with BRAF V600-dependent advanced solid tumors: preliminary results, 2014-05-06
PAK Signaling Drives Acquired Drug Resistance to MAPK Inhibitors inBRAF-mutant Melanomas, 2017-09-27
Efficacy of Anti-PD-1 Agents in Acral and Mucosal Melanoma, 2016-08-17
Understanding the biology of melanoma and therapeutic implications, 2014-05-31
Defining T cell states associated with response to checkpoint immunotherapy in melanoma, 2018-11-01
Resistance to checkpoint blockade therapy through inactivation of antigen presentation, 2017-10-26
Targeted next generation sequencing identifies markers of response to PD-1 blockade, 2016-09-26
Evolution of Delayed Resistance to Immunotherapy in a Melanoma Responder, 2021-05-03
Budesonide treatment for microscopic colitis from immune checkpoint inhibitors, 2019-11-07
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts National Harbor, MD, USA. 9-13 November 2016, 2016-12-08
Immune Responses in Checkpoint Myocarditis Across Heart, Blood, and Tumor, 2023-09-18
The Great Debate at "Melanoma Bridge”, Napoli, December 2nd, 2017, 2018-04-17
Molecular Pathways and Mechanisms of BRAF in Cancer Therapy, 2022-11-01
Effect of Cancer Stage on Adverse Kidney Outcomes in Patients Receiving Immune Checkpoint Inhibitors for Melanoma, 2022-09-08
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors, 2018-03-19
Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade, 2023-03-02
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one National Harbor, MD, USA. 9-13 November 2016, 2016-11-16
Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies, 2016-08-17
Immune checkpoint inhibitors in challenging populations, 2017-02-27
Focus on Breast Cancer
Insurance Check
Search for your insurance carrier and choose your plan type
Locations
Practice
Practice
Practice
Affiliated Hospitals
- Recipient of 31
hospital awardsAmerica's 250 Best Hospitals Award™ (2025, 2024)
Top in the nation for overall patient experience based on nine measures related to doctor and nurse communication, hospital cleanliness and noise levels, and medication and post-discharge care instructions
View all awardsSurgical Care Excellence Award™ (2025)
Top in the nation for overall patient experience based on nine measures related to doctor and nurse communication, hospital cleanliness and noise levels, and medication and post-discharge care instructions
View all patient feedbackHow patients felt about the care they received at this hospital.
90%Patients said they were given information about recovering at home6% higher than the national average
86%Patients would recommend the hospital to friends and family21% higher than the national average
- Recipient of 31
hospital awardsAmerica's 250 Best Hospitals Award™ (2025)
Top in the nation for overall patient experience based on nine measures related to doctor and nurse communication, hospital cleanliness and noise levels, and medication and post-discharge care instructions
View all awardsOutstanding Patient Experience Award™ (2024, 2023, 2022)
Top in the nation for overall patient experience based on nine measures related to doctor and nurse communication, hospital cleanliness and noise levels, and medication and post-discharge care instructions
View all patient feedbackHow patients felt about the care they received at this hospital.
91%Patients said they were given information about recovering at home7% higher than the national average
84%Patients said that nurses always listened to them and explained things well9% higher than the national average
- Recipient of 15
hospital awardsAmerica's 250 Best Hospitals Award™ (2025, 2024)
Top in the nation for providing excellence in patient safety by preventing infections, medical errors, and other preventable complications
View all awardsPatient Safety Excellence Award™ (2024)
Top in the nation for providing excellence in patient safety by preventing infections, medical errors, and other preventable complications
View all patient feedbackHow patients felt about the care they received at this hospital.
89%Patients said they were given information about recovering at home5% higher than the national average
83%Patients said that doctors always listened to them and explained things well7% higher than the national average
Compare with other Medical Oncologists
Compare Dr. Sullivan with our nearby Medical Oncologists at Tufts Medical Center.
Make an appointment at Tufts Medical Center today at
(617) 263-8322.
Leave a review
How was your experience with Dr. Sullivan?